| November
29, 2001
A grant in the amount
of $50,000 was awarded to Dr. Bob Elliott of Diatranz in support
of his next porcine islet cell transplantation trial. This next
trial will use improved encapsulation devices, and as with his last
trial, no immunosuppression will be used.
See the following abstracts
for more information on this exciting research.
No evidence of infection
with porcine endogenous retrovirus in recipients of encapsulated
porcine islet xenografts.
Elliott RB, Escobar L, Garkavenko O, Croxson MC, Schroeder BA, McGregor
M, Ferguson G, Beckman N, Ferguson S.
 click
here to view
Islet cell transplantation
for the treatment of diabetes mellitus.
Kendall WF Jr, Collins BH, Opara EC.
click
here to view
Increase in beta-cell
mass in transplanted porcine neonatal pancreatic cell clusters is
due to proliferation of beta-cells and differentiation of duct cells.
Trivedi N, Hollister-Lock J, Lopez-Avalos MD, O'Neil JJ, Keegan
M, Bonner-Weir S, Weir GC.
click
here to view
In vitro and in vivo
performance of porcine islets encapsulated in interfacially photopolymerized
poly(ethylene glycol) diacrylate membranes.
Cruise GM, Hegre OD, Lamberti FV, Hager SR, Hill R, Scharp DS, Hubbell
JA.
click
here to view
Back
to Research Updates
|
